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Antagonists of 5-Hydroxytryptamine (5-HT) receptors are well known to inhibit
gastrointestinal (GI)-motility and transit in a variety of mammals, including humans.
Originally, these observations had been interpreted by many investigators (including us)
as evidence that endogenous 5-HT plays a major role in GI motility. This seemed a logical
assumption. However, the story changed dramatically after recent studies revealed that
5-HT antagonists still blocked major GI motility patterns (peristalsis and colonic migrating
motor complexes) in segments of intestine depleted of all 5-HT. Then, these results were
further supported by Dr. Gershons’ laboratory, which showed that genetic deletion of all
genes that synthesizes 5-HT hadminor, or no inhibitory effects on GI transit in vivo. If 5-HT
was essential for GI motility patterns and transit, then one would expect major disruptions
in motility and transit when 5-HT synthesis was genetically ablated. This does not occur.
The inhibitory effects of 5-HT antagonists on GI motility clearly occur independently of
any 5-HT in the gut. Evidence now suggests that 5-HT antagonists act on 5-HT receptors
in the gut which are constitutively active, and don’t require 5-HT for their activation.
This would explain a long-standing mystery of how 5-HT antagonists inhibit gut motility
in species like mice, rats, and humans where 5-HT is not an enteric neurotransmitter.
Studies are now increasingly demonstrating that the presence of a neurochemical in
enteric neurons does not mean they function as neurotransmitters. Caution should be
exercised when interpreting any inhibitory effects of 5-HT antagonists on GI motility.
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HISTORICAL PERSPECTIVE OF THE ROLE OF 5-HT IN GUT
MOTILITY
It is well-established that the majority of 5-HT in the body is synthesized in the gut
wall (Erspamer, 1954). Since this discovery, a number of studies have proposed that the
release of serotonin from the GI tract may play an important role in the control of
different neurogenic GI motility patterns, such as peristalsis, and migrating complexes in
the small and large intestine (Büllbring and Lin, 1957; Bülbring and Lin, 1958; Bülbring
et al., 1958; Grider et al., 1996; Jin et al., 1999; Heredia et al., 2009). Abundant
circumstantial evidence has been presented to support this hypothesis. Evidence comes from the
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fact that (1) the largest quantity of serotonin in the body is
synthesized in enterochromaffin cells in the mucosa (Erspamer,
1954), (2) high concentrations of 5-HT can be dynamically
released from the mucosa (Bertrand, 2006; Keating and Spencer,
2010; Spencer et al., 2011) (3) exogenous 5-HT potently
stimulates GI motility (Büllbring and Lin, 1957; Bülbring and
Lin, 1958; Keating and Spencer, 2010; Spencer et al., 2011), and
(4) numerous antagonists of 5-HT receptors can inhibit, or block
peristalsis and reduce propulsion of contents (Grider et al., 1996;
Kadowaki et al., 1996; Heredia et al., 2009), including rectal
distension reflexes (Shimatani et al., 2003). Collectively, these
studies provided a strong, albeit indirect case, that 5-HTmay play
an important role in GI motility.
Despite seemingly convincing data supporting a role for
endogenous 5-HT in the control of GI motility, the notion
that endogenous 5-HT played a major role in control of GI
motility was spectacularly revised in recent years, based on
independent findings from different laboratories (Keating and
Spencer, 2010; Yadav et al., 2010; Li et al., 2011; Spencer
et al., 2011; Heredia et al., 2013; Sia et al., 2013a). These
recent studies revealed that depletion of 5-HT from enteric
neurons and complete removal of the mucosa and submucosal
plexus did not prevent distension-evoked peristalsis (Figure 1)
(Spencer et al., 2011; Sia et al., 2013a), nor CMMCs (Spencer
et al., 2013). This is opposite to what one would expect
if 5-HT was essential for these motor patterns. Then, Dr.
Gershons’ laboratory (Yadav et al., 2010; Li et al., 2011) revealed
that deletion of the gene responsible for 5-HT synthesis in
enterochromaffin (EC) cells (>95% of the 5-HT in the body)
did not cause any decrease in transit in vivo (Yadav et al.,
2010; Li et al., 2011). Finally, it was revealed that in segments
of gut depleted of all detectable 5-HT, selective antagonists
of 5-HT3 and 5-HT4 receptors still had the same, or greater,
inhibitory effects on gut motility (Spencer et al., 2013) (see below,
Figure 2).
PREVIOUS MISCONCEPTIONS
REGARDING THE INTERPRETATION OF
THE MECHANISMS OF ACTION OF 5-HT3
ANTAGONISTS ON COLONIC MOTILITY
We made a conspicuous error (Bush et al., 2001) when
interpreting the effects of a 5-HT3 antagonist (Alosetron)
on propagating neurogenic motor patterns in the isolated
mouse colon. We studied colonic migrating motor complexes
(CMMCs) and found that they were potently abolished by the
selective 5-HT3 receptor antagonist alosetron, at physiologically
relevant concentrations (Bush et al., 2001). Based on this
result, we speculated that 5-HT itself maybe important for the
generation of CMMCs, by activating 5-HT3 receptors. This
turned out to be an incorrect hypothesis because it is now
known that CMMCs still occur when all 5-HT is depleted
from the mouse colon (Spencer et al., 2013). Furthermore, 5-
HT3 antagonists still had the same potent inhibitory effects
on CMMCs in preparations of mouse colon that lacked all
endogenous 5-HT (Spencer et al., 2013)—further refuting our
original hypothesis (Bush et al., 2001). This revealed that the
inhibitory effects of 5-HT3 antagonists on CMMCs occurred
independently of endogenous 5-HT. In hindsight this result now
makes sense, because no laboratory could ever find evidence
that 5-HT is an enteric neurotransmitter in mouse colon
(Furukawa et al., 1986; Nurgali et al., 2004) and of course,
5-HT is only synthesized in 1% of enteric neurons (Costa
et al., 1996). The observation that CMMCs in mouse colon
and peristaltic waves in guinea-pig colon (Spencer et al., 2011;
Sia et al., 2013a) still occurred when all detectable 5-HT was
depleted from the colon made it clear that 5-HT was not
required for their generation and propagation, regardless of
the effects of any antagonists. The major unanswered question
then, was how do 5-HT3 antagonists block CMMCs in 5-
HT depleted segments of colon? The most likely answer that
has now emerged is that 5-HT3 and/or 5-HT4 receptors can
be constitutively active and contribute to the background
excitability of enteric neurons even in the absence of any 5-
HT. And, when these receptors are blocked by 5-HT3 and 5-
HT4 antagonists, they temporarily reduce the excitability of the
neural network (Figure 2). Unequivocal evidence that 5-HT3
and 5-HT4 receptors are not required for distension-evoked
peristalsis was demonstrated when in the continued presence of
both antagonists, peristalsis recovers after a temporary blockade
(Figure 2).
FIGURE 1 | (A) Immunohistochemical staining of a myenteric ganglion with
antibodies against 5-HT. Varicose 5-HT immunoreactive nerve axons ramify
within myenteric ganglia and internodal strands.(B) Distension-evoked
peristalsis elicited by insertion of an artificial fecal pellet. (C) After injection of
reserpine into conscious guinea-pigs, all 5-HT is depleted from enteric ganglia.
(D) Despite removal of all the mucosa and submucosal plexus and depletion of
5-HT from myenteric ganglia, distension-evoked peristalsis still reliably occurs.
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FIGURE 2 | Repetitive peristaltic contractions evoked by maintained colonic distension with a fixed artificial fecal pellet are only temporarily inhibited
by 5-HT3 and 5-HT4 antagonists in isolated guinea-pig distal colon. (A) Shows that increasing concentrations of ondansetron and SDZ-205-557 have only
temporary effects on inhibiting distension-evoked peristaltic contractions in control distal colon. (B) Shows 5-HT is present in varicose nerve axons of myenteric
ganglia. (C) In reserpine-treated guinea-pigs to deplete neuronal 5-HT and which also have their mucosa and submucosal plexus removed, maintained colonic
distension by a fecal pellet continues to evoke repetitive peristaltic contractions. Simultaneous addition of increasing concentrations of ondansetron and SDZ-205-557
temporarily inhibited peristaltic contractions, which recovered in the continued presence of both antagonists. The two black arrows indicated when peristaltic





Some investigators have assumed that the presence of a
neurochemical in enteric neurons implies there must be
a functional role of each of these neurochemical. This is
an incorrect assumption. There are many (>20) different
neurochemicals known to be synthesized in enteric neurons
(including 5-HT, galanin, GABA, glutamate, CCK, etc.). But,
most do not meet the criteria as “neurotransmitters” and lack
any evidence they cause any post synaptic effector responses
following neuronal stimulation. 5-HT is one such example. 5-
HT is synthesized in <1% of enteric neurons (Costa et al., 1996),
but it does not cause postsynaptic potentials in enteric neurons of
most species studied.
Another misconception that has been made is that 5-HT
receptors can only be activated by their natural cognate ligand
(5-HT). Evidence has been presented that in heterologously
expressed receptor operated (Hu and Peoples, 2008) and G-
protein coupled 5-HT receptors (Berthouze et al., 2005) can
be activated without the presence of any exogenous 5-HT.
This means that both ligand-gated and G-protein coupled 5-
HT receptors can be constitutively active. Knowledge of this
is mechanism is very important in potentially explaining the
long-standing conundrum as to why 5-HT antagonists (like
ondansetron and alosetron) can still potently inhibit GI motility
in mice and other species, like rats and humans, where 5-HT
is not a functional enteric neurotransmitter (Sia et al., 2013a).
This knowledge would also now clearly explain why these 5-HT
antagonists often have only temporary effects to block peristalsis,
where peristalsis can recover in the continued presence of the
antagonists (Sia et al., 2013b).
WHY 5-HT FAILS THE CRITERIA TO BE A
NEUROTRANSMITTER IN THE ENS OF
MOST SPECIES
According to the classic definition of a neurotransmitter, it is “..a
substance that is released at a synapse of by one neuron and that
affects another cell, either neuron or effector organ, in a specific
manner. . . ” (Kandel et al., 2000). Despite exhaustive attempts
from different laboratories, intracellular electrophysiological
recordings from enteric neurons in mice (Furukawa et al., 1986;
Nurgali et al., 2004), rats (Brookes et al., 1988) and humans
(Brookes et al., 1987) have not be able to record any fast
synaptic potentials that could be attributed to endogenous 5-
HT, even though clear evidence exists that 5-HT receptors are
endowed on enteric neuronal cell membranes. In these latter
three species, all fast synaptic potentials in enteric neurons
are abolished, or almost blocked by nicotinic antagonists. We,
and other laboratories, tried desperately to demonstrate reliable
evidence that serotonin is a neurotransmitter in the enteric
nervous system. But, we failed (Spencer and Smith, 2004). In
our experiments, in Dr Smith’s laboratory, all fast synaptic inputs
were blocked by hexamethoniun and we found no evidence
that 5-HT is a neurotransmitter in the colon of guinea-pigs
(Spencer and Smith, 2004). In guinea-pig small intestine, small
amplitude fast excitatory post synaptic potentials have been
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demonstrated to occur in about 10% of enteric neurons (Galligan
et al., 2000; Nurgali et al., 2003; Furness, 2006). Perhaps the
most interesting aspect of these findings is that despite 5-HT not
being a neurotransmitter in human, rat, or mouse enteric nerves,
5-HT antagonists can clearly reduce intestinal transit in these
species (Balfour et al., 2000; Bush et al., 2001). The mechanism
how this works had remained elusive, until it was recently
discovered that 5-HT3 and 5-HT4 receptors in the gut are likely
to be constitutively active (Sia et al., 2013b). Another important
possibility to explain the inhibitory effects of 5-HT3 antagonists
on gut motility is that 5-HT3 antagonists block non-serotonergic
receptors. In an interesting study on guinea-pig enteric neurons,
fast synaptic potentials evoked by nerve stimulation and by
ionophoretic application of exogenous acetylcholine could be
reduced by 5-HT3 antagonists (Vanner and Surprenant, 1990).
The IC-50 of the 5-HT3 antagonists ICS-930, GR 38032F, and
MDL 7222 to inhibit 5-HT-mediated fast synaptic potentials was
12, 100 nM, and 3µM, respectively. It was shown that these
same 5-HT3 antagonists could inhibit acetylcholine-induced fast
EPSPs in the same preparation although considerably greater
concentrations (up to 100-fold higher IC-50 concentrations) in
the micromolar range were required (Vanner and Surprenant,
1990). In our experiments, low nanomolar concentrations of the
5-HT3 antagonist ondansetron still potently inhibit CMMCs in
isolated segments of whole mouse colon that are depleted of all
5-HT (Spencer et al., 2013).
WHY WOULD A NEUROCHEMICAL (LIKE
5-HT) BE SYNTHESIZED IN THE ENTERIC
NERVOUS SYSTEM IF IT DOES NOT
FUNCTION AS A NEUROTRANSMITTER?
There is now overwhelming evidence in mammals that a variety
of proteins, receptors, neurotransmitters, ion channels, even
whole organs have no essential function for survival on earth.
For example, there is no essential function of nipples on men, the
appendix in the GI tract, the coccyx bone, or tail that still develops
in some humans, the helix in the ear, the tonsils, the arrector
pili (goose bumps), wisdom teeth, plica semilunaris (nictitating
membrane) in the eye lid, the sinus cavities in the skull, even
the gall bladder is not essential. Humans can live successfully
without any of these. The question that is then commonly raised
is why are these cells, neurochemicals, receptors, even whole
organs (e.g., gall bladder) synthesized in the body if they do not
have an essential function for normal day-day life? The answer
is that they are evolutionary vestiges. Evolutionary pressure and
environmental change determine their relative importance in
each species. It is entirely possible that different neurochemicals
such as 5-HT, GABA, glutamate, CCK etc. which rarely, or never
fulfill a functional role in the gut of healthy mammals, may
become very important in disease states. However, it is important
to recognize that a change in expression of “putative” enteric
neurotransmitters, receptors, ion channels etc., during disease
may be misinterpreted as being causally-related to the disease,
rather than a consequence of the disease.
CONCLUDING REMARKS
There has been a paradigm shift in recent years in our
understanding of endogenous 5-HT in GI motility and transit.
The observation that endogenous 5-HT itself is not required for
major GI motor patterns, including normal orderly transit of
intestinal contents is a major change from original hypotheses;
and a major step forward in gastroenterology (Yadav et al.,
2010; Li et al., 2011). Another recent major breakthrough is
that 5-HT antagonists retain their potent inhibitory effects
on GI motility in segments of bowel depleted of all 5-HT
(Sia et al., 2013b). This has led to that notion that 5-HT3
and 5-HT4 receptors in the GI tract are likely to exhibit
constitutively active and that acute application of 5-HT3 and
5-HT4 antagonists can affect GI motility, despite the lack of
all detectable 5-HT. We have now learnt from our mistakes
and we take supreme caution when interpreting any effects
of 5-HT antagonists on GI motility. Any future studies on
the GI tract that demonstrate changes in cellular activity
caused by antagonism of 5-HT receptors should entertain
the possibility that the 5-HT receptors maybe constitutively
active.
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